Leverage Shares 2X Long PLTR Daily ETFPLTG

Leverage Shares 2X Long PLTR Daily ETF (PLTG) is a concentrated exchange-traded instrument that targets 2X the daily return of Palantir Technologies Inc. (PLTR), resetting its exposure each trading day. The wrapper’s mandate is simple, but its marketing is less so: the fund promises thematic exposure to Palantir’s AI-driven data platform via a daily concentrated ETF, despite the fact that Palantir itself has not endorsed the product or filed any related materials with the SEC.

The Nasdaq listing shows the ticker PLTG trading on the exchange, but the fund’s SEC filings stop at the registration statement and do not include earnings, revenue, or guidance from Palantir. The fund’s expense ratio is disclosed as 0.95% per annum, which is the only figure the filings explicitly confirm. What the filings do not show is any evidence of Palantir’s involvement in the ETF’s creation, marketing, or ongoing operation, leaving investors to wonder whether the wrapper is riding on Palantir’s coattails or simply piggybacking on its volatility.

The fund’s mandate requires daily resets to achieve 2X exposure, a mechanism that amplifies both gains and losses within a single session. The FINRA Fund Analyzer confirms the 0.95% expense ratio but does not opine on the suitability of daily concentrated products for retail investors or the long-term arithmetic of compounding daily resets. The SEC EDGAR search reveals no filings from Palantir related to PLTG, meaning the company’s own disclosures offer no insight into the ETF’s holdings, performance, or strategy.

The Nasdaq market page for PLTG provides real-time quotes and trading data, but the source does not explain the fund’s holdings composition beyond the stated mandate. The fund’s holdings are not disclosed in the filings provided, and the SEC documents do not include portfolio snapshots or top-ten lists. Investors relying on the fund’s page for composition details will find only the ticker and a link to the prospectus, which itself is not parsed for specific holdings or concentration limits in this run.

What remains unproven is the scale of Palantir’s indirect or direct benefit from the ETF’s existence. The filings do not show any agreement, contract, or endorsement between Palantir and Leverage Shares, nor do they confirm whether Palantir receives any fees, data access, or promotional support in connection with PLTG. The fund’s performance will therefore reflect the daily resets of PLTR’s share price without any visible tie to Palantir’s operational or financial disclosures, leaving the thematic link resting solely on the ETF’s marketing language.

Next steps for clarity would include a prospectus review that explicitly lists the fund’s top holdings and concentration limits, or a Palantir filing that mentions the ETF by name. Absent those, the product’s pitch outruns its disclosure, and the wrapper’s fee remains the most concrete detail in the file.